Market Cap 16.45M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 14,600
Avg Vol 64,528
Day's Range N/A - N/A
Shares Out 1.88M
Stochastic %K 10%
Beta 1.38
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
SmallCapGrowth
SmallCapGrowth Dec. 18 at 7:33 PM
Small Cap Stock Alert: $BCTX BriaCell’s - HOT HOT PENNY https://investorshangout.com/post/view?id=6807650
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 7:31 PM
Small Cap Stock Alert: $BCTX BriaCell’s - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6807647
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 6:10 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 5:20 PM
Small Cap Stock Alert: $BCTX BriaCell’s Phase 3 clinical trial in metastatic breast cancer featured as “clinical trial to watch in 2026” in Nature Medicine. “Eleven clinical trials that will shape medicine in 2026” BriaCell anticipates reporting top line data as early as H1-2026. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html #BCTX #STOCKSTOBUY #STOCKSTOWATCH #TEAMHIGHALERT #STOCKS
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 4:27 PM
MOMO'S BREAKOUT BOARD : Cancer Stock News Alert: $BCTX Phase 3 T... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177080364 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 3:59 PM
Cancer Stock News Alert: $BCTX Phase 3 Trial Featured in Nature Medicine - “Eleven clinical trials that will shape medicine in 2026” BriaCell anticipates reporting top line data as early as H1-2026 $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 3:09 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html #BCTX #STOCKSTOBUY #STOCKSTOWATCH #TEAMHIGHALERT #STOCKS
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 3:04 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
2maligators
2maligators Dec. 18 at 2:42 PM
$BCTX why don’t they want this over $13-14?
1 · Reply
SmallCapVoice
SmallCapVoice Dec. 18 at 12:31 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. https://www.globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
Latest News on BCTX
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 2 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 4 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation


BriaCell CEO Letter to Shareholders

May 20, 2025, 7:30 AM EDT - 7 months ago

BriaCell CEO Letter to Shareholders


BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Apr 23, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025


BriaCell Therapeutics Announces Closing of Public Offering

Feb 5, 2025, 4:05 PM EST - 11 months ago

BriaCell Therapeutics Announces Closing of Public Offering


SmallCapGrowth
SmallCapGrowth Dec. 18 at 7:33 PM
Small Cap Stock Alert: $BCTX BriaCell’s - HOT HOT PENNY https://investorshangout.com/post/view?id=6807650
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 7:31 PM
Small Cap Stock Alert: $BCTX BriaCell’s - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6807647
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 6:10 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 5:20 PM
Small Cap Stock Alert: $BCTX BriaCell’s Phase 3 clinical trial in metastatic breast cancer featured as “clinical trial to watch in 2026” in Nature Medicine. “Eleven clinical trials that will shape medicine in 2026” BriaCell anticipates reporting top line data as early as H1-2026. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html #BCTX #STOCKSTOBUY #STOCKSTOWATCH #TEAMHIGHALERT #STOCKS
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 4:27 PM
MOMO'S BREAKOUT BOARD : Cancer Stock News Alert: $BCTX Phase 3 T... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177080364 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 3:59 PM
Cancer Stock News Alert: $BCTX Phase 3 Trial Featured in Nature Medicine - “Eleven clinical trials that will shape medicine in 2026” BriaCell anticipates reporting top line data as early as H1-2026 $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 3:09 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html #BCTX #STOCKSTOBUY #STOCKSTOWATCH #TEAMHIGHALERT #STOCKS
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 3:04 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. NEWS: https://globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
2maligators
2maligators Dec. 18 at 2:42 PM
$BCTX why don’t they want this over $13-14?
1 · Reply
SmallCapVoice
SmallCapVoice Dec. 18 at 12:31 PM
Nature Medicine highlights BriaCell’s Phase 3 metastatic breast cancer trial as one of the “11 clinical trials that will shape medicine in 2026.” Top line data expected as early as H1 2026. $BCTX featured as a clinical trial to watch. https://www.globenewswire.com/news-release/2025/12/18/3207604/0/en/Eleven-clinical-trials-that-will-shape-medicine-in-2026-BriaCell-Phase-3-Trial-Featured-in-Nature-Medicine.html
0 · Reply
ProfessorDman1
ProfessorDman1 Dec. 18 at 12:31 PM
$BCTX “Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
1 · Reply
superguild
superguild Dec. 17 at 10:45 PM
$BCTX i see the stock went up a bit to attract some suckers then straight back down as usual.
0 · Reply
DunkenInvest
DunkenInvest Dec. 16 at 4:46 PM
$BCTX at this point I just hope this will crash under 5$, so I can get some cheep Christmas gifts. Let it go down until March, then it can go boom 🤗
2 · Reply
JediGreen
JediGreen Dec. 16 at 6:22 AM
$BCTX I just hope I have my extra 30 to 40k to dump into this if she starts to move around these days on google. Bullish baby.
1 · Reply
JediGreen
JediGreen Dec. 16 at 6:12 AM
$BCTX briacell therapeutics phase 3 completion time estimate - Google Search https://www.google.com/search?q=briacell+therapeutics+phase+3+completion+time+estimate&sca_esv=8efe466fbfa838b2&ei=_fRAaevuA5-qw8cPyM_bmQg&oq=briacell+therapeutics+phase%C2%A0&gs_lp=EhNtb2JpbGUtZ3dzLXdpei1zZXJwIh1icmlhY2VsbCB0aGVyYXBldXRpY3MgcGhhc2XCoCoCCAAyBRApGKABMgUQKRigATIGEAAYFhgeMgUQIRigATIFECEYoAEyBRAhGKABMgUQIRigATILEAAYgAQYhgMYigUyCBAAGKIEGIkFMgUQABjvBUjaSlD1CVjHHXACeAGQAQCYAWCgAdoEqgEBN7gBAcgBAPgBAZgCCaACswXCAgUQKRirAsICChApGLADGNYEGEfCAgoQABiwAxjWBBhHwgINEAAYgAQYsAMYQxiKBcICBRAAGIAEwgIQEC4YgAQY0QMYQxjHARiKBcICChAAGIAEGEMYigXCAgcQKRigARgKwgIFECEYqwKYAwCIBgGSBwM1LjSgB7QrsgcDMy40uAejBcIHBTItNi4zyAc7gAgA&sclient=mobile-gws-wiz-serp
1 · Reply
Rohtan
Rohtan Dec. 16 at 4:15 AM
$BCTX look at the number of shares owned by institutions. Is that not laughable? They don’t even have confidence in it.
1 · Reply
FredFlintstock
FredFlintstock Dec. 16 at 12:49 AM
$BCTX quite in here today, thats the sound of people losing their money
0 · Reply
Kirubin
Kirubin Dec. 15 at 6:04 PM
$BCTX where are the 🤡🤡🤡pumpers at?
0 · Reply
JediGreen
JediGreen Dec. 14 at 11:59 PM
$BCTX watching the The thing on my 5K$ Sony 85in 9 series TV that I made and baught from market money amassing TV. Get the darks of a OLED but the brights of a LED TV heard it’s the brightest on the market amassing TV. Love it.
0 · Reply
JediGreen
JediGreen Dec. 14 at 11:44 PM
$BCTX any of you guys want to get drunk and go skiing. I do. Sounds fun if I can bank out on this I’m going skiing trashed out of my mind 😆.
0 · Reply
Sb123321
Sb123321 Dec. 13 at 5:06 PM
$BCTX what do people think about naked short of BCTXW against a 1/10 long position in BCTXZ. Cash wise flat to slightly positive. Net you end up short a warrant that matures in FEB '26 that has an adjusted exercise price of $796.88 and requires 150 warrants to convert into 1 share. You are also net long warrants that that have an exercise price of $52.50 require 10 warrants per exercise with a maturity date April '30. Most likely case the "W" roll off worthless and you have free warrants that extend well past the P3 timeline. This is obviously the bullish structure. For bears I guess you just sell the "W" and bank the cash as chance of any value an maturity is very very small. I see little downside to this structure other than transaction costs (need to minimize) and tradable size as it probably isn't worth doing for much less than 50,000 "W" vs 5,000 "Z". Thoughts?
1 · Reply
JediGreen
JediGreen Dec. 13 at 4:19 AM
$BCTX I meant to say is prepaid expenses.
0 · Reply